BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem CellsGemma Molyneux, Matthew J. Smalley, Jorge S. Reis‐Filho et al.|Cell stem cell|2010Cited by 814
<i>FGFR1</i> Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast CancerNicholas C. Turner, Alan Ashworth, Jorge S. Reis‐Filho et al.|Cancer Research|2010Cited by 740
Prediction of Breast Cancer Risk Based on Profiling With Common Genetic VariantsNasim Mavaddat, Kristiina Aittomäki, Paul D.P. Pharoah et al.|JNCI Journal of the National Cancer Institute|2015Cited by 570
Germline mutations in RAD51D confer susceptibility to ovarian cancerChey Loveday, Nazneen Rahman, Clare Turnbull et al.|Nature Genetics|2011Cited by 545
Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targetsNicholas C. Turner, Jorge S. Reis‐Filho, Marc J. van de Vijver et al.|Oncogene|2010Cited by 416